Business Operation
Source: National Cancer Institute Thesaurus
NCI Thesaurus OID: 2.16.840.1.113883.3.26.1.1
|
SPL Acceptable Term |
Code |
|---|---|
| ANALYSIS | C25391 |
| API/FDF ANALYTICAL TESTING | C101509 |
| API MANUFACTURE | C82401 |
| CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY | C101511 |
| DISTRIBUTE | C201565 |
| DISTRIBUTES DRUG PRODUCTS UNDER OWN PRIVATE LABEL | C73608 |
| FDF MANUFACTURE | C101510 |
| HUMAN DRUG COMPOUNDING OUTSOURCING FACILITY | C112113 |
| IMPORT | C73599 |
| IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING | C101512 |
| LABEL | C84732 |
| MANUFACTURE | C43360 |
| MEDICATED ANIMAL FEED MANUFACTURE | C84635 |
| OUTSOURCING ANIMAL DRUG COMPOUNDING | C122061 |
| PACK | C84731 |
| PARTICLE SIZE REDUCTION | C84386 |
| POSITRON EMISSION TOMOGRAPHY DRUG PRODUCTION | C91403 |
| RELABEL | C73607 |
| REPACK | C73606 |
| SALVAGE | C70827 |
| SIP FOREIGN SELLER | C175317 |
| STERILIZE | C84382 |
| THIRD-PARTY LOGISTICS PROVIDER | C118412 |
| TRANSFILL | C125710 |
| UNITED STATES AGENT | C73330 |
| WHOLESALE DRUG DISTRIBUTOR | C118411 |